ONE BIO: Building a Thriving Biotech Ecosystem in Africa
Release Date: 07/26/2023
Africa Biotech Conversations
This session focuses on the essential legal and funding strategies for early-stage biotech startups, emphasizing the importance of intellectual property (IP) management, legal structures, and the role of due diligence in attracting investors. The panel discusses common pitfalls, the significance of contracts, and the challenges of commercializing university IP. They also explore the timing of freedom to operate studies and the evolving landscape of biotech investment. For this session, the featured guests were: Chyreene Truluck – Partner at Spoor & Fisher, specializing in intellectual...
info_outline OneBio Innovation Center: A Pioneering Space for Biotech Startups in AfricaAfrica Biotech Conversations
In this episode of the Africa Biotech Conversations Podcast, host Adrienne Leussa welcomes Erin Rencken, General Manager of the newly launched OneBio Innovation Center (OBIC) in Cape Town, South Africa. The special episode features a live recording from the launch event and a detailed discussion about OBIC's mission, offerings, and community-building efforts. Erin outlines the center's vision to provide biotech startups with essential lab space, equipment, and a collaborative environment. The conversation also highlights the support received from the Technology Innovation Agency...
info_outline Proteinea: Pioneering the Development of the First Fully African-Originated DrugAfrica Biotech Conversations
In this episode of the "Africa Biotech Conversations" podcast, host Adrienne Leussa interviews Abdulaziz El Gamal, the co-founder and Chief Product Officer of Proteinea. Proteinea, based in Cairo and Boston, is a tech-bio company focused on leveraging AI to develop next-generation biologics, particularly antibodies with enhanced efficacy, safety, and convenience. Key Points from the Episode: Company Background: Proteinea was founded in early 2020, right before the global pandemic, which influenced its strategic direction and provided a real-time showcase of biotech's potential in health...
info_outline AMA Series on Investment Funding for Biotech - The Art of Valuation for Early-Stage Biotech StartupsAfrica Biotech Conversations
The LinkedIn Live session, part of the AMA series on "The Art of Valuation," focused on valuation strategies for biotech startups at early and post-Series A stages. Moderated by Dr. Adrienne Leussa, the discussion featured finance experts Olufemi Elegbe, CFA and Sewu-Steve Tawia. Key highlights included the importance of financial literacy for biotech entrepreneurs, methods for accurately valuing biotech startups, and strategies for enhancing valuation after Series A. The session also emphasized the need for tailored communication when presenting valuations to investors and included practical...
info_outline AMA Series on Investment Funding for Biotech - Understanding the Investment Ecosystem (Pre-seed Focus)Africa Biotech Conversations
In this insightful episode of the "Ask Me Anything" series on funding and investment, the focus was on early-stage biotech entrepreneurs in Africa. Adrienne was joined by Gian-Marco Melfi, a partner at OneBio Venture Studios, who shared his expertise on the unique challenges and strategies relevant to securing investment in the biotech sector. The discussion covered the intricacies of biotech investments, including the importance of understanding the investment landscape, targeting the right type of investors (such as angel investors, family offices, and venture capitalists), and...
info_outline AMA Series on Investment Funding for Biotech - Building Investor RelationsAfrica Biotech Conversations
In this comprehensive session of the ongoing dialogue with African biotech leaders, the focus was on building and maintaining investor relationships. Joining Adrienne were seasoned experts, including Dr. Vuyisile Phehane and Gian-Marco Melfi, who are regular contributors, along with first-time guests Natasha Drapeau and Frank Schwarz from Cohesion Bureau. The discussion covered best practices for engaging with investors, emphasising the importance of communication, the strategic presentation of business plans, and the need for biotech startups to clearly articulate their value...
info_outline AMA Series on Investment Funding for Biotech - Common Pitfalls in Securing FundingAfrica Biotech Conversations
In this episode of the "Ask Me Anything" series under the Dialogue with African Biotech Leaders, experts Gian-Marco Melfi and Vuyisile Phehane discuss the nuances of funding for biotech startups. Focusing on the early stages of startup financing, the conversation explores the challenges startups face in securing funding, the importance of aligning with the right investors, and effective strategies for engaging potential backers. Gian-Marco Melfi, from One Bio Venture Studio, emphasises the significance of building strong, capable teams, while Vuyisile Phehane from the Technology Innovation...
info_outline AMA Series on Investment Funding for Biotech - Where's the Money and How Do I Get It?Africa Biotech Conversations
In this first episode of the "Ask Me Anything" (AMA) series focused on Investment Funding for biotech, held live on LinkedIn, we delved into the intricate world of funding for biotech startups. The session features profound insights from Dr. Vuyisile Phehane, the Executive: Bio-Economy at South Africa's National Technology Innovation Agency (TIA), and Mr. Gian-Marco Melfi, an investment principal at One BioVenture Studio. Together, they explore the diverse sources of funding available to biotech startups in Africa and provide practical advice on navigating the complex investment landscape....
info_outline Dialogue with African Biotech Leaders: Your 2024 Biotech Growth Plan from Africa and BeyondAfrica Biotech Conversations
Welcome to another retrospective episode of the Dialogue with African Biotech Leaders. In this special session, titled "Going Global: Your 2024 Biotech Growth Plan from Africa and Beyond," we explore cutting-edge strategies for biotech leaders aiming for significant growth in the 2024. This episode is packed with insights from two distinguished speakers: Erica Sosnowski: Managing Partner at Sosna and Co, a leading business development firm in the life sciences industry, with a stellar track record of closing over $250 million in deals. Jennifer Andrews: CEO of Freshly Marketing, a seasoned...
info_outline Dialogue with African Biotech Leaders: Navigating Funding and InvestmentAfrica Biotech Conversations
Welcome to another insightful episode of the Dialogue with African Biotech Leaders. In this episode, we focus on a critical aspect of biotechnology entrepreneurship—funding and investment. This episode was recorded as a live plenary session at BIO Africa 2023 in Durban, South Africa, and features in-depth discussions on funding challenges and opportunities in the African biotech landscape. Join our distinguished panelists: Dr. Allama Elmehdi: CEO of Prophamedis International from Mauritania, sharing insights on the funding landscape in West Africa, particularly Francophone Africa, and the...
info_outlineIn this episode of the Africa Biotech Conversations podcast, our host Dr Adrienne Leussa engages in a captivating discussion with Gian-Marco Melfi, a partner at One Bio Venture Studio. One Bio is a venture capital fund that focuses on investing in local biotech startups in Africa. Marco, a biomedical scientist with a background in biochemistry and biomedical sciences, shares his fascinating journey from research to startups and now investing and funding early-stage biotech companies.
Marco discusses his experience at Cambridge University, where he supported biotech startups and spinouts through the Milner Therapeutics Institute. He highlights the advantages of building a biotech hub in Cape Town, South Africa, including the availability of talented scientific graduates and the potential for creating supportive ecosystems for startups.
The two delve into the competitive advantage of building a biotech business in Africa, emphasising natural biodiversity and genetic diversity. Marco explains One Bio's approach to making first-time investments, focusing on competitive advantages, team dynamics, and advisory support to refine startup ideas. He underscores the importance of understanding the science behind investments and how the One Bio team's scientific background contributes to their success.
The conversation also covered government involvement in the biotech industry in South Africa. Marco highlights the support mechanisms provided by the Department of Science and Innovation, such as soft grant funding and supporting funds and platforms. They discuss the thriving bioeconomy in South Africa and the significant role played by the government's bioeconomy strategy.
Moving forward, Marco shares a story of one of their portfolio companies in the future of food or food tech space, showcasing their resilience in closing a pre-seed round with international investors. The challenges of raising international capital are explored, along with the tips and learnings gained from their fundraising journey.
Marco emphasises the importance of building networks proactively and developing resilience and connections beyond scientific ideas. They stress the need for thorough preparation and the ability to answer technical, business development, financial, and budgeting questions.
Marco reflects on his time studying biochemistry at Stellenbosch University, crediting senior biochemists' mentorship for solidifying his interest in the field. He also shares an inspiring story of a founder's dedication and determination witnessed in the Milner incubator.
Marco discusses the commitment and sacrifice required to build a successful biotech company. He draws inspiration from notable biotech companies like Kappa Bio Systems and Gyroscope Therapeutics. Marco reveals One Bio's plans for expansion into other African countries like Nigeria, Kenya, and Egypt.
Crucial elements for a thriving biotech ecosystem are highlighted, including access to capital, support mechanisms, and talent. Marco emphasises the importance of shared access laboratories and support offerings to foster a sense of community among startups. He acknowledges the growing number of biotech startups in South Africa and other regions and emphasises the need to learn from other ecosystems while tailoring approaches to the local context.
Tune in to this enlightening episode as Marco shares their expertise, experiences, and vision for the future of biotech in Africa.